FR13C0008I2 - PHOSPHONOCEPHEM DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR USE - Google Patents

PHOSPHONOCEPHEM DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR USE

Info

Publication number
FR13C0008I2
FR13C0008I2 FR13C0008C FR13C0008C FR13C0008I2 FR 13C0008 I2 FR13C0008 I2 FR 13C0008I2 FR 13C0008 C FR13C0008 C FR 13C0008C FR 13C0008 C FR13C0008 C FR 13C0008C FR 13C0008 I2 FR13C0008 I2 FR 13C0008I2
Authority
FR
France
Prior art keywords
preparation process
phosphonocephem
derivatives
phosphonocephem derivatives
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR13C0008C
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Lim
Original Assignee
Takeda Pharmaceutical Co Lim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=18417716&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR13C0008(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Pharmaceutical Co Lim filed Critical Takeda Pharmaceutical Co Lim
Publication of FR13C0008I1 publication Critical patent/FR13C0008I1/fr
Application granted granted Critical
Publication of FR13C0008I2 publication Critical patent/FR13C0008I2/en
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65613—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. cephalosporins and analogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
FR13C0008C 1997-12-19 2013-02-06 PHOSPHONOCEPHEM DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR USE Active FR13C0008I2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP35149997 1997-12-19
PCT/JP1998/005709 WO1999032497A1 (en) 1997-12-19 1998-12-17 Phosphonocephem derivatives, process for the preparation of the same, and use thereof

Publications (2)

Publication Number Publication Date
FR13C0008I1 FR13C0008I1 (en) 2013-03-22
FR13C0008I2 true FR13C0008I2 (en) 2013-08-16

Family

ID=18417716

Family Applications (1)

Application Number Title Priority Date Filing Date
FR13C0008C Active FR13C0008I2 (en) 1997-12-19 2013-02-06 PHOSPHONOCEPHEM DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR USE

Country Status (19)

Country Link
US (1) US6417175B1 (en)
EP (2) EP1043327B1 (en)
JP (3) JP3467418B2 (en)
KR (1) KR100384047B1 (en)
CN (2) CN1194980C (en)
AT (1) ATE430155T1 (en)
AU (1) AU1683299A (en)
BE (1) BE2013C004I2 (en)
CA (1) CA2314564C (en)
CY (2) CY1109276T1 (en)
DE (1) DE69840796D1 (en)
DK (1) DK1043327T3 (en)
ES (1) ES2325139T3 (en)
FR (1) FR13C0008I2 (en)
LU (1) LU92134I2 (en)
NL (1) NL300568I2 (en)
PT (1) PT1043327E (en)
TW (1) TW473479B (en)
WO (1) WO1999032497A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002014333A1 (en) 2000-08-10 2002-02-21 Takeda Chemical Industries, Ltd. Phosphonocephem compound
US20070238719A1 (en) * 2005-05-10 2007-10-11 Hopkins Scott J Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures
US20070238720A1 (en) * 2005-05-10 2007-10-11 Hopkins Scott J Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures
US20070249577A1 (en) * 2005-05-10 2007-10-25 Hopkins Scott J Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures
CN101456871B (en) * 2007-06-22 2011-01-12 山东轩竹医药科技有限公司 Cephalosporin derivative containing mercaptothiazole
CN101868240A (en) 2007-09-21 2010-10-20 阿斯利康(瑞典)有限公司 Soluble dosage forms containing cephem derivatives suitable for parenteral administration
BRPI0916885B8 (en) 2008-08-28 2021-05-25 Astrazeneca Ab pharmaceutical composition
WO2010096798A1 (en) * 2009-02-23 2010-08-26 Forest Laboratories Holdings Limited Novel cephem compounds useful for the treatment of bacterial infections
CA2774772A1 (en) * 2009-09-21 2011-03-24 Forest Laboratories Holdings Limited Compositions and methods for treating bacterial infections using ceftaroline
FR2951171A1 (en) 2009-10-09 2011-04-15 Novexel NOVEL SODIUM SALT OF A CRYSTALLIZED ENANTIOMER AZABICYCLIC COMPOUND AND NOVEL POLYMORPHIC AND PSEUDOPOLYMORPHIC FORMS AND THEIR PREPARATION
KR102143660B1 (en) 2011-06-17 2020-08-11 화이자 안티-인펙티브스 에이비 Process for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof
US20140350240A1 (en) 2011-12-07 2014-11-27 Ranbaxy Laboratories Limited Process for preparing ceftaroline salts or hydrates thereof
JP6301346B2 (en) * 2012-10-19 2018-03-28 サンド・アクチエンゲゼルシヤフト New method for producing ceftaroline fosamil
CN102977124B (en) * 2012-12-13 2014-11-26 山东诚创医药技术开发有限公司 Preparation method of 7beta-[(phenylacetyl) amino]-3-[4-(1-methyl-4-pyridine onium)-2-thiothiazole]-3-cephem-4-benzhydryl carboxylate
CN104870457B (en) * 2012-12-20 2017-08-08 桑多斯股份公司 The new crystalline form of Ceftaroline Fosamil
CN105612166B (en) 2014-02-21 2019-02-19 上海盟科药业有限公司 Water-soluble (O- carbonyl) phosphoramidate prodrugs for the treatment of
CN106565784B (en) * 2016-10-31 2019-02-26 瑞阳制药有限公司 The purification process of Ceftaroline Fosamil disodium salt
CN110872322B (en) * 2018-08-29 2022-08-02 上海博志研新药物技术有限公司 Preparation method of cefaloside acetate monohydrate and intermediate thereof
CN113072567B (en) * 2021-03-26 2022-10-14 海南海灵化学制药有限公司 Synthesis process of latamoxef sodium

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5941999B2 (en) * 1975-07-24 1984-10-11 武田薬品工業株式会社 Method for producing cefem or venam compounds
US4268509A (en) * 1978-07-10 1981-05-19 Fujisawa Pharmaceutical Co., Ltd. New cephem compounds and processes for preparation thereof
JPS5511600A (en) * 1978-07-10 1980-01-26 Fujisawa Pharmaceut Co Ltd Cephem compound, its salt, their preparation and remedy and prophylactic for microbism containing mainly the same
FR2511372A1 (en) * 1981-08-17 1983-02-18 Rhone Poulenc Sante NEW DERIVATIVES OF CEPHALOSPORINE AND THEIR PREPARATION
JPS5931791A (en) * 1982-07-19 1984-02-20 Fujisawa Pharmaceut Co Ltd Novel cephem compound, its preparation and preventive and remedy for bacterial infectious disease
US4563449A (en) * 1982-07-19 1986-01-07 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
JPS62238291A (en) * 1986-04-10 1987-10-19 Fujisawa Pharmaceut Co Ltd Cephem compound and pharmaceutically acceptable salt thereof
US4978663A (en) * 1989-08-16 1990-12-18 Hoechst-Roussel Pharmaceuticals Inc. 5-(1-aminocyclohexyl)-2(1H)-pyridinone compounds which have pharmaceutical utility
JP3514495B2 (en) 1992-10-02 2004-03-31 エーザイ株式会社 Method for producing halogenated aminothiadiazolylacetic acid derivatives
JP3927262B2 (en) * 1995-07-19 2007-06-06 武田薬品工業株式会社 Cephem compound, production method thereof and antibacterial composition
JPH10265488A (en) * 1997-03-27 1998-10-06 Takeda Chem Ind Ltd Phosphonocephem derivative

Also Published As

Publication number Publication date
EP1043327A1 (en) 2000-10-11
CY1109276T1 (en) 2014-07-02
JP2009114202A (en) 2009-05-28
DE69840796D1 (en) 2009-06-10
WO1999032497A1 (en) 1999-07-01
CY2013003I2 (en) 2015-08-05
DK1043327T3 (en) 2009-08-17
EP1043327B1 (en) 2009-04-29
JP3467418B2 (en) 2003-11-17
KR100384047B1 (en) 2003-05-14
AU1683299A (en) 1999-07-12
NL300568I1 (en) 2016-01-18
KR20010015885A (en) 2001-02-26
BE2013C004I2 (en) 2018-01-29
PT1043327E (en) 2009-07-02
CA2314564A1 (en) 1999-07-01
FR13C0008I1 (en) 2013-03-22
US6417175B1 (en) 2002-07-09
CN1679595A (en) 2005-10-12
TW473479B (en) 2002-01-21
EP2080765A1 (en) 2009-07-22
JPH11255772A (en) 1999-09-21
CN1194980C (en) 2005-03-30
EP1043327A4 (en) 2001-12-12
CY2013003I1 (en) 2014-07-02
CN1679595B (en) 2010-05-12
LU92134I2 (en) 2013-03-18
NL300568I2 (en) 2016-01-18
CA2314564C (en) 2008-11-18
CN1282335A (en) 2001-01-31
ES2325139T3 (en) 2009-08-26
JP2001048893A (en) 2001-02-20
ATE430155T1 (en) 2009-05-15

Similar Documents

Publication Publication Date Title
FR13C0008I2 (en) PHOSPHONOCEPHEM DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR USE
FR2784107B1 (en) SURFACE MODIFIED CELLULOSE MICROFIBRILLES, THEIR PREPARATION PROCESS, AND THEIR USE
FR2732680B1 (en) CERAMID-LIKE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USE
PT901474E (en) ARIL-PYRIMIDINE DERIVATIVES.
EE03482B1 (en) Quinazoline derivatives, process for their preparation and use
FR2660556B1 (en) MICROSPHERES, THEIR PREPARATION PROCESS AND THEIR USE.
EE9800265A (en) Erythromycin derivatives, process for their preparation and use as pharmaceuticals
EE04721B1 (en) Phenylxanthine derivatives, processes for their preparation and use
EE9800302A (en) Arylglycinamide derivatives, process for their preparation and use, and pharmaceutical preparation
NO975977D0 (en) Substituted purine derivatives, processes for their preparation and use
PT922050E (en) 3-DESCLADINOSE-2,3-ANYDROERITROMYCIN DERIVATIVES
FR2680506B1 (en) PROCESS FOR THE PREPARATION OF BETA-PHENYLISOSERIN DERIVATIVES AND THEIR USE.
NO960499D0 (en) Antineurodegeneratively-active 10-aminoalipatyldibenz [b, foxepins
PT931087E (en) NEW PYRANOSID DERIVATIVES
MA24472A1 (en) PROCESS
MA24470A1 (en) PROCESS
FR2755439B1 (en) ARYLOXYPROPANOLAMINE DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATIONS
GR3035834T3 (en) Benzoxazindione derivatives, process for their preparation and their use
MA26590A1 (en) THIAZOLE DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR USE.
FR2765874B1 (en) 6-PYRROLIDIN-2-YLPYRINDINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
ZA9810403B (en) New epothilon derivatives, process for their preparation and their pharmaceutical use.
BR9701404A (en) 1,25-dihydroxy-16,22,23-trisdehydro-cholecal-ciferol derivatives
DE69711853T2 (en) Pyridinecarboxamide DERIVATIVES
FR2725450B1 (en) AMINOPLASTS, PROCESS FOR THEIR PREPARATION AND THEIR USE
FR2769627B1 (en) (3-OXOISOINDOLINE-1-YLIDINE) PROPANEDINITRILE DERIVATIVES AND THEIR PREPARATION PROCESS